Ferronova-clinical trials update

August 01, 2022

Ferronova-clinical trials update

Current MRI techniques are susceptible to underestimation of the true tumour volume, with MRIguided therapies potentially improved through the utilisation of molecular MRI targeting tumour markers.

For more information on Ferronova’s recent #prostatecancer study:
https://lnkd.in/gda8Z2YK



Also in News

MARKET UPDATE-10th AUG 2022
MARKET UPDATE-10th AUG 2022

August 10, 2022

The Reserve Bank issued new quarterly economic forecasts, with expectations that growth would be 3.5 per cent this year and settle to 1.75 per cent in 2023 and 2024. Inflation is forecasts to reach in the region of 7.75 per cent by the end of the 2022 and decline to around the top of the target range (2-3 per cent) by the end of 2024.
ENA Respiratory has achieved a significant milestone
ENA Respiratory has achieved a significant milestone

August 08, 2022

ENA Respiratory Pty Ltd has achieved a significant milestone with the successful enrolment of all 123 participants in its Phase 2a flu-challenge study conducted at hVIVO.
True or false? ‘AI does not influence radiologists’ performance’
True or false? ‘AI does not influence radiologists’ performance’

August 08, 2022

Whiterabbit.ai wants to challenge a ‘longstanding assumption made by the majority of peer-reviewed publications’ about healthcare AI